PDL BioPharma, Inc.
September 8, 2017
PDL BioPharma, Inc., an Incline Village company that manages a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries, announced that John P. McLaughlin, PDL's president and chief executive officer, will present at two investor conferences in September.
McLaughlin will attend the Rodman & Renshaw 19th Annual Global Investment Conference Monday, Sept. 11, and the 2017 Cantor Fitzgerald Global Healthcare Conference Monday, Sept. 25, both in New York City.
Trending In: News Briefs
- Los Angeles investor acquires Reno’s Mira Loma Shopping Center
- Tired of being tired? ‘Sleep’ suggests a paradigm shift (Biz & Books review)
- City National Bank hosts its 2018 Economic & Investment Forum in Reno
- Toll Brothers announced as first homebuilder at Reno’s Rancharrah development
- Business Leads from Northern Nevada Business Weekly for April 9-13, 2018